159 related articles for article (PubMed ID: 34617137)
1. KP772 overcomes multiple drug resistance in malignant lymphoma and leukemia cells in vitro by inducing Bcl-2-independent apoptosis and upregulation of Harakiri.
Kater L; Kater B; Jakupec MA; Keppler BK; Prokop A
J Biol Inorg Chem; 2021 Dec; 26(8):897-907. PubMed ID: 34617137
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).
Heffeter P; Jakupec MA; Körner W; Chiba P; Pirker C; Dornetshuber R; Elbling L; Sutterlüty H; Micksche M; Keppler BK; Berger W
Biochem Pharmacol; 2007 Jun; 73(12):1873-86. PubMed ID: 17445775
[TBL] [Abstract][Full Text] [Related]
3. The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro.
Wilke NL; Abodo LO; Frias C; Frias J; Baas J; Jakupec MA; Keppler BK; Prokop A
Biomed Pharmacother; 2022 Dec; 156():113974. PubMed ID: 36411649
[TBL] [Abstract][Full Text] [Related]
4. (2,6-Dimethylphenyl)arsonic Acid Induces Apoptosis through the Mitochondrial Pathway, Downregulates XIAP, and Overcomes Multidrug Resistance to Cytostatic Drugs in Leukemia and Lymphoma Cells In Vitro.
Wilke N; Frias C; Berkessel A; Prokop A
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731935
[TBL] [Abstract][Full Text] [Related]
5. Novel gold(I) complexes induce apoptosis in leukemia cells via the ROS-induced mitochondrial pathway with an upregulation of Harakiri and overcome multi drug resistances in leukemia and lymphoma cells and sensitize drug resistant tumor cells to apoptosis in vitro.
Ahrweiler-Sawaryn MC; Biswas A; Frias C; Frias J; Wilke NL; Wilke N; Berkessel A; Prokop A
Biomed Pharmacother; 2023 May; 161():114507. PubMed ID: 36958194
[TBL] [Abstract][Full Text] [Related]
6. The role of the intrinsic FAS pathway in Titanocene Y apoptosis: The mechanism of overcoming multiple drug resistance in malignant leukemia cells.
Kater L; Claffey J; Hogan M; Jesse P; Kater B; Strauss S; Tacke M; Prokop A
Toxicol In Vitro; 2012 Feb; 26(1):119-24. PubMed ID: 21986259
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).
Heffeter P; Jakupec MA; Körner W; Wild S; von Keyserlingk NG; Elbling L; Zorbas H; Korynevska A; Knasmüller S; Sutterlüty H; Micksche M; Keppler BK; Berger W
Biochem Pharmacol; 2006 Feb; 71(4):426-40. PubMed ID: 16343446
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium Complex HB324 Induces Apoptosis via Mitochondrial Pathway with an Upregulation of Harakiri and Overcomes Cisplatin Resistance in Neuroblastoma Cells In Vitro.
Wilke NL; Burmeister H; Frias C; Ott I; Prokop A
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674465
[TBL] [Abstract][Full Text] [Related]
9. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a cobalt (III) salen complex that induces apoptosis in Burkitt like lymphoma and leukemia cells, overcoming multidrug resistance in vitro.
Hopff SM; Onambele LA; Brandenburg M; Berkessel A; Prokop A
Bioorg Chem; 2020 Nov; 104():104193. PubMed ID: 32947134
[TBL] [Abstract][Full Text] [Related]
11. Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative.
Kater B; Hunold A; Schmalz HG; Kater L; Bonitzki B; Jesse P; Prokop A
J Cancer Res Clin Oncol; 2011 Apr; 137(4):639-49. PubMed ID: 20544219
[TBL] [Abstract][Full Text] [Related]
12. A metal-free salalen ligand with anti-tumor and synergistic activity in resistant leukemia and solid tumor cells via mitochondrial pathway.
Hopff SM; Wang Q; Frias C; Ahrweiler M; Wilke N; Wilke N; Berkessel A; Prokop A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2591-2607. PubMed ID: 34213662
[TBL] [Abstract][Full Text] [Related]
13. Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia.
Iacovelli S; Ricciardi MR; Allegretti M; Mirabilii S; Licchetta R; Bergamo P; Rinaldo C; Zeuner A; Foà R; Milella M; McCubrey JA; Martelli AM; Tafuri A
Oncotarget; 2015 Oct; 6(31):32089-103. PubMed ID: 26392332
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
[TBL] [Abstract][Full Text] [Related]
15. beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein.
Wu CH; Rastegar M; Gordon J; Safa AR
Oncogene; 2001 Oct; 20(48):7006-20. PubMed ID: 11704825
[TBL] [Abstract][Full Text] [Related]
16. ABT-737 induces apoptosis in mantle cell lymphoma cells with a Bcl-2high/Mcl-1low profile and synergizes with other antineoplastic agents.
Touzeau C; Dousset C; Bodet L; Gomez-Bougie P; Bonnaud S; Moreau A; Moreau P; Pellat-Deceunynck C; Amiot M; Le Gouill S
Clin Cancer Res; 2011 Sep; 17(18):5973-81. PubMed ID: 21821698
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma.
de Jong MRW; Langendonk M; Reitsma B; Nijland M; van den Berg A; Ammatuna E; Visser L; van Meerten T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801186
[TBL] [Abstract][Full Text] [Related]
19. sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell.
Tian D; Das SG; Doshi JM; Peng J; Lin J; Xing C
Cancer Lett; 2008 Feb; 259(2):198-208. PubMed ID: 18037229
[TBL] [Abstract][Full Text] [Related]
20. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice.
Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S
Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
